These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 18308687

  • 1. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA.
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [Abstract] [Full Text] [Related]

  • 2. Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.
    Shah AM, Pfeffer MA, Hartley LH, Moyé LA, Gersh BJ, Rutherford JD, Lamas GA, Rouleau JL, Braunwald E, Solomon SD.
    Am J Cardiol; 2010 Oct 01; 106(7):911-6. PubMed ID: 20854949
    [Abstract] [Full Text] [Related]

  • 3. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
    Velazquez EJ, Francis GS, Armstrong PW, Aylward PE, Diaz R, O'Connor CM, White HD, Henis M, Rittenhouse LM, Kilaru R, van Gilst W, Ertl G, Maggioni AP, Spac J, Weaver WD, Rouleau JL, McMurray JJ, Pfeffer MA, Califf RM, VALIANT registry.
    Eur Heart J; 2004 Nov 01; 25(21):1911-9. PubMed ID: 15522470
    [Abstract] [Full Text] [Related]

  • 4. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
    Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Køber L, Pfeffer MA, Solomon SD.
    Eur Heart J; 2007 Feb 01; 28(3):326-33. PubMed ID: 17251259
    [Abstract] [Full Text] [Related]

  • 5. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
    Shamshad F, Kenchaiah S, Finn PV, Soler-Soler J, McMurray JJ, Velazquez EJ, Maggioni AP, Califf RM, Swedberg K, Kober L, Belenkov Y, Varshavsky S, Pfeffer MA, Solomon SD, VALsartan In Acute myocardial iNfarcTion (VALIANT) Trial Investigators.
    Am Heart J; 2010 Jul 01; 160(1):145-51. PubMed ID: 20598985
    [Abstract] [Full Text] [Related]

  • 6. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
    Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ, Lamas GA, Gordon D, Bernstein V, Pfeffer MA, Survival and Ventricular Enlargement Trial.
    Am Heart J; 2004 Aug 01; 148(2):356-64. PubMed ID: 15309009
    [Abstract] [Full Text] [Related]

  • 7. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
    Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, Velazquez EJ, Califf RM, Scheiman JM, Solomon SD.
    Eur Heart J; 2009 Sep 01; 30(18):2226-32. PubMed ID: 19556260
    [Abstract] [Full Text] [Related]

  • 8. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction.
    Ezekowitz JA, Kaul P, Bakal JA, Armstrong PW, Welsh RC, McAlister FA.
    J Am Coll Cardiol; 2009 Jan 06; 53(1):13-20. PubMed ID: 19118718
    [Abstract] [Full Text] [Related]

  • 9. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
    Thune JJ, Signorovitch JE, Kober L, McMurray JJ, Swedberg K, Rouleau J, Maggioni A, Velazquez E, Califf R, Pfeffer MA, Solomon SD.
    Eur J Heart Fail; 2011 Feb 06; 13(2):148-53. PubMed ID: 21037250
    [Abstract] [Full Text] [Related]

  • 10. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.
    Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D.
    J Am Coll Cardiol; 2006 Mar 07; 47(5):962-8. PubMed ID: 16516078
    [Abstract] [Full Text] [Related]

  • 11. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.
    Szummer KE, Solomon SD, Velazquez EJ, Kilaru R, McMurray J, Rouleau JL, Mahaffey KW, Maggioni AP, Califf RM, Pfeffer MA, White HD, VALIANT Registry.
    Eur Heart J; 2005 Oct 07; 26(20):2114-9. PubMed ID: 15972293
    [Abstract] [Full Text] [Related]

  • 12. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA.
    Circulation; 2004 Sep 21; 110(12):1572-8. PubMed ID: 15364810
    [Abstract] [Full Text] [Related]

  • 13. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study.
    Fosbøl EL, Seibaek M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia ON Dofetilide Study Group.
    Int J Cardiol; 2010 Apr 30; 140(3):279-86. PubMed ID: 19095316
    [Abstract] [Full Text] [Related]

  • 14. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M.
    Med Sci Monit; 2009 Jun 30; 15(6):PH40-8. PubMed ID: 19478711
    [Abstract] [Full Text] [Related]

  • 15. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA.
    Arch Intern Med; 2004 Nov 08; 164(20):2273-9. PubMed ID: 15534166
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ.
    Am Heart J; 2008 Jan 08; 155(1):87-93. PubMed ID: 18082495
    [Abstract] [Full Text] [Related]

  • 17. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.
    Eur Heart J; 2009 May 08; 30(9):1057-65. PubMed ID: 19168526
    [Abstract] [Full Text] [Related]

  • 18. The timing of development and subsequent clinical course of heart failure after a myocardial infarction.
    Torabi A, Cleland JG, Khan NK, Loh PH, Clark AL, Alamgir F, Caplin JL, Rigby AS, Goode K.
    Eur Heart J; 2008 Apr 08; 29(7):859-70. PubMed ID: 18353754
    [Abstract] [Full Text] [Related]

  • 19. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA, Furberg CD, O'Meara ES, Psaty BM, Kuller L, Powe NR, Manolio T.
    Circulation; 2006 May 09; 113(18):2177-85. PubMed ID: 16651468
    [Abstract] [Full Text] [Related]

  • 20. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
    Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L.
    Int J Cardiol; 2005 Sep 30; 104(2):184-9. PubMed ID: 16168812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.